‡ In these countries please contact our distributor

    2015 second quarter and half year results

    Strong performance - improved underlying revenue growth, trading profit margin and earnings. Full year guidance maintained

    We announced our second quarter and half year results ended 27 June 2015 on Thursday 30 July 2015 at 7.00am BST/2.00am EDT.


    Read the press release on our website here

    Adobe Acrobat PDF icon Read the full announcement here (PDF 650KB)

    Listen to a playback of the 8.30am analyst call here

    Adobe Acrobat PDF icon View the presentation slides here (PDF 330KB)

    Adobe Acrobat PDF icon View the transcipt here (PDF 208KB)


    Investors/ Analysts
    Ingeborg Øie +44 (0) 20 7960 2285
    Smith & Nephew plc

    Charles Reynolds +44 (0) 20 7401 7646
    Smith & Nephew plc

    Ben Atwell / Deborah Scott / Matthew Cole  +44 (0) 20 3727 1000
    FTI Communications


    Forward-looking Statements

    This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.